PARIS, May 18, 2011 /PRNewswire/ -- One-year results from the 278-patient multi-center, prospective, single-arm study conducted at 16 sites in Europe and Israel were presented today at the EuroPCR 2011 Congress in Paris.

NATICK, Mass., Feb.

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today a

Aug. 17--Boston Scientific Corp. and the Israeli company Medinol Ltd.

Aug. 13-- In the middle of a high-stakes trial, Boston Scientific said it is holding settlement talks with Medinol Ltd., the Israeli company that used to be its partner in the stent business.